Scientists test new Drug's safety in first human trial
Knowledge-focused
Completed
This was an early-stage study to check the safety and side effects of a new drug called ALT-BB4 in healthy volunteers. Researchers gave the drug to 290 healthy adults to see how their bodies reacted to it and how the drug was processed. The main goal was to find out if it caused …
Phase: PHASE1 • Sponsor: Alteogen, Inc. • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC